You may also like

MOMA Gets $150M to Make Small Molecules Against ATPases, Laborers of the Cell
Third Rock-Backed Abata Secures $95M for T-reg Cell Therapy Against MS
EQRx Taps Zeitgeist, Raises $200m For Innovative Drugs at Aggressive Low Prices
Third Rock and Friends Bet $110M On Thrive, a Hopkins-Inspired Cancer Screening Startup